1458653-12-7

Basic information

• Product Name: 3-Methyl-3-azetidinemethanol HCl
• Synonyms: 3-Methyl-3-azetidinemethanol HCl;(3-methylazetidin-3-yl)methanol hydrochloride;(3-METHYLAZETIDIN-3-YL)METHANOL HCL
• CAS NO: 1458653-12-7
• Molecular Formula: C5H12ClNO
• Molecular Weight: 137.60788
• Mol File: 1458653-12-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Methyl-3-azetidinemethanol HCl(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Methyl-3-azetidinemethanol HCl(1458653-12-7)
• EPA Substance Registry System: 3-Methyl-3-azetidinemethanol HCl(1458653-12-7)

Safety Data

• Hazardous Substances Data: 1458653-12-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Methyl-3-azetidinemethanol HCl is used as a key intermediate for the synthesis of various medicinal products, contributing to the development of new drugs and pharmaceuticals. Its unique chemical properties and reactivity make it a valuable component in the creation of a diverse range of pharmaceutical compounds.
Used in Organic Synthesis:
In the field of organic synthesis, 3-Methyl-3-azetidinemethanol HCl is utilized as a reagent to facilitate various chemical reactions. Its ability to participate in a wide array of reactions, including the formation of new bonds and the modification of existing ones, makes it an indispensable tool for chemists working on the development of new organic compounds.
Used in Drug Manufacturing:
3-Methyl-3-azetidinemethanol HCl is employed as a crucial component in the manufacturing process of several drugs. Its presence in the synthesis pathway allows for the production of pharmaceuticals with specific therapeutic properties, ensuring the efficacy and safety of the final product.

Upstream product

• 1363382-91-5 3-hydroxymethyl-3-methyl-azetidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS

The present invention relates to compounds of general formula I, wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS

The present invention relates to compounds of general formula I, (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS

The present invention relates to compounds of general formula (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.